Centro Oncológico Del Norte

What Centro Oncológico Del Norte does

Centro Oncológico Del Norte (CON) is a public, government-owned specialized oncology center headquartered in Antofagasta, Chile, and operating under the Servicio de Salud Antofagasta within Chile's FONASA public health network. Consolidated in its current form in 2010, it functions as the macrozonal reference center for oncology services across Chile's Macrozona Norte — four northern regions — providing radiotherapy, brachytherapy, chemotherapy, pain management, and palliative care to a population dispersed across a vast, mining-heavy territory with limited alternative specialized capacity. The institution has 56 employees and is structurally integrated into the GES (Garantías Explícitas en Salud) framework, meaning the Chilean public system is its de facto sole payer and its patient volume is centrally allocated rather than market-driven.

Its service portfolio spans the full outpatient oncology pathway. The radiotherapy and brachytherapy programs were refreshed through a CLP 3,400 million linear accelerator replacement and a CLP 490 million radiotherapy planning system investment, restoring core radiation oncology capacity. The chemotherapy day hospital was expanded from 9 to 20 infusion chairs, more than doubling systemic-therapy throughput, while the dedicated Pain Unit treats more than 500 patients. Institutional credibility rests on two external validations: a December 2023 Superintendencia de Salud accreditation and a November 2023 IAEA QUATRO peer-review audit, which benchmarks its radiation oncology practice against international standards. A clinical research partnership with Bradford Hill Norte, signed in October 2021, extends the service surface into oncology clinical trials.

CON does not operate as a commercial enterprise. Revenue mechanics are government budget transfers routed through Servicio de Salud Antofagasta, with patient access governed by FONASA/GES protocols rather than commercial pricing. Capital allocation decisions are publicly funded and directed at sustaining its monopoly over specialized oncology within the macrozone. Ricardo Baeza Letelier was appointed director in April 2025, signaling a leadership refresh consistent with the ongoing capacity and accreditation agenda.

Name

Centro Oncológico Del Norte

Legal name

Centro Oncológico del Norte

Website

https://centrooncologicodelnorte.cl

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Centro Oncológico Del Norte is a public, government-owned oncology reference center headquartered in Antofagasta, Chile, serving Chile's Macrozona Norte (four northern regions) with radiotherapy, brachytherapy, chemotherapy, pain management, and palliative care under the FONASA/GES public health network.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Oncology treatment services
• Cancer care center
• Radiotherapy services
• Chemotherapy treatment
• Palliative care services

Headquarters

HQ city

Antofagasta

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Others

Revenue model

1. Public Healthcare Services: CON operates as a public healthcare establishment within Chile's national health system (FONASA/GES). Services are provided to beneficiaries of the public healthcare system, with costs covered through government healthcare financing mechanisms. The center receives funding through the Servicio de Salud Antofagasta and participates in national cancer care programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Centro Oncológico del Norte (CON) is a public high-complexity oncology center that provides comprehensive cancer diagnosis, treatment, and palliative care services to adult patients in Chile's Macrozona Norte. The center delivers radiotherapy with linear accelerator technology, chemotherapy administration, brachytherapy, specialized pain intervention procedures, and supportive clinical services including imaging, clinical laboratory with tumor marker testing, pharmacy, clinical psychology, and rehabilitation. CON operates as a public healthcare establishment within Chile's FONASA/GES national health system.

Product overview

Centro Oncológico del Norte (CON) is a public high-complexity oncology healthcare establishment serving the Macrozona Norte of Chile, covering regions of Arica and Parinacota, Tarapacá, Antofagasta, and Atacama. The facility operates as an integrated cancer treatment center offering specialized services including Radioterapia (radiation therapy), Braquiterapia (brachytherapy), Quimioterapia (chemotherapy), and Alivio del Dolor y Cuidados Paliativos (pain management and palliative care). The center provides comprehensive support services including medical imaging, clinical laboratory with tumor marker testing, pharmacy, clinical nutrition, psychology, physical medicine and rehabilitation, and social work. The institution is structured under strategic Direction, Medical Subdirection for clinical management, and Administrative Subdirection for operational support. The center was consolidated through integration of Centro Asistencial Norte (founded 2007) and Centro Oncológico de Antofagasta (inaugurated 2010).

Differentiator

Problem solved

Functional benefit

Products and services

• Radioterapia (Radiotherapy) High-complexity radiation therapy unit providing external beam radiation treatment for cancer patients, using modern linear accelerator technology including a Varian Unique unit for advanced techniques.
• Braquiterapia (Brachytherapy) Specialized internal radiation therapy service for treating various cancers including cervical, lung, and other tumor types, pioneering lung brachytherapy in the northern macrozone.
• Quimioterapia (Chemotherapy) Oncology chemotherapy unit for administration of anti-cancer drug treatments to patients, with capacity for 100+ patients daily.
• Alivio del Dolor y Cuidados Paliativos (Pain Relief and Palliative Care) Specialized unit providing pain management and palliative care services for cancer patients, addressing physical, psychological and spiritual needs, serving more than 500 patients from the northern macrozone.
• Unidad de Intervención del Dolor (Pain Intervention Unit) Pain intervention unit performing procedures such as nerve blockades using fluoroscopic techniques to alleviate severe cancer-related pain, unique in the public healthcare system of the northern macrozone.
• Imagenología (Medical Imaging) Medical imaging services including mammography, CT scanning, and diagnostic radiology for cancer detection and treatment planning.
• Laboratorio Clínico (Clinical Laboratory) Clinical laboratory providing hematology, biochemistry, hormonal tests, tumor markers (PSA, CA125, CEA), and specialized oncohematological pathology testing; the only facility performing tumor marker service in northern Chile.
• Medicina Física y Rehabilitación (Physical Medicine and Rehabilitation) Physical rehabilitation services including kinesiology, therapeutic exercises, and home visits for cancer patients.
• AUGE-GES Garantías Oncológicas (GES/AUGE Oncology Guarantees) Guaranteed oncology health benefits delivered under Chile's Explicit Health Guarantees (GES/AUGE) program, ensuring coverage for guaranteed cancer care for FONASA beneficiaries.

Quantifiable outcome

• Pain reduction of 70-80% in patients treated by Pain Intervention Unit
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered minor, core, flagship and strategic.

• Sociedad Chilena de Farmacia OncológicaminorStrategic or Co-development Partner · 4 March 2025Professional oncology pharmacy society involved in SLAGO 2025 symposium coordination, with CON director participation.
• Higea SaludcoreTechnology or Integration · 21 December 2023Healthcare accreditation entity that conducted the three-day evaluation process for CON's accreditation as an accredited healthcare provider by the Superintendencia de Salud.
• IAEA (International Atomic Energy Agency)flagshipTechnology or Integration · 20 November 2023CON's Radiotherapy Unit requested and underwent voluntary QUATRO quality audit by IAEA (UN agency) to evaluate radiotherapy infrastructure, procedures, patient and equipment protocols, radiation protection, staffing, and professional training programs.
• BHPminorOthers · 4 October 2022Mining company providing financial support for corporation Yo Mujer's breast cancer patient education program conducted at CON facilities.
• Corporación Yo MujerminorStrategic or Co-development Partner · 4 October 2022Breast cancer support organization providing educational workshops and psycho-oncology support for women undergoing breast cancer treatment at CON, with BHP financial support.
• Bradford Hill NortestrategicStrategic or Co-development Partner · 4 October 2021Clinical research collaboration between Servicio de Salud Antofagasta and Bradford Hill Norte enabling access to clinical trials and latest-generation cancer drugs for FONASA beneficiaries.
• Servicio de Salud AntofagastacoreStrategic or Co-development PartnerCON is an integral part of the Red Asistencial del Servicio de Salud Antofagasta, coordinating patient care, referrals, and resource sharing with regional hospitals and healthcare facilities including Hospital Regional, Hospital de Calama, Hospital de Tocopilla, Hospital de Taltal, and Hospital de Mejillones.
• CONAC (Corporación Nacional del Cáncer)coreStrategic or Co-development PartnerCONAC operates patient accommodation houses (Casas de Acogida) in partnership with CON, providing free lodging for cancer patients traveling from other regions of the northern macrozone for treatment at the center.

Scale indicators8 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Red de Salud UC CHRISTUS - Oncología: University-affiliated private Chilean health network with comprehensive oncology services including radiotherapy, chemotherapy, and clinical trial access. Comparable as a multi-modality cancer care provider in Chile, drawing some of the same patient population who could otherwise access CON.
• Instituto Nacional del Cáncer (Chile): Chile's national public cancer institute headquartered in Santiago. Provides the same comprehensive specialty oncology services (radiotherapy, chemotherapy, brachytherapy, palliative care) and serves as a public reference center — the closest direct functional peer to CON within Chile's public oncology network.
• Hospital de Cáncer de Barretos / A.C. Camargo Cancer Center: A.C. Camargo is one of Brazil's leading specialty oncology hospitals, offering full cancer treatment modalities including radiotherapy, chemotherapy, brachytherapy, and supportive care. Comparable high-complexity public-affiliated cancer hospital with similar service portfolio to CON.
• Hospital del Salvador - Unidad de Oncología (Chile): Public hospital in Santiago with a major oncology unit serving as a regional public-sector referral center. Comparable public-sector oncology provider with similar radiotherapy, chemotherapy, and palliation offerings, though embedded within a larger general hospital rather than a standalone specialty center.
• Fundación Arturo López Pérez (FALP): Chile's largest private non-profit cancer center, located in Santiago. Operates a comprehensive cancer hospital with radiotherapy, chemotherapy, brachytherapy and imaging — comparable in service mix and complexity to CON, differing primarily as private/non-profit vs. public and in geographic catchment.
• Clínica Alemana de Santiago - Centro de Oncología: Private Chilean hospital network with a comprehensive oncology center offering radiotherapy (incl. linear accelerators), chemotherapy, and supportive care. Competitor in Chilean oncology; comparable service portfolio though operating under a private/prepaid model rather than CON's public FONASA/GES model.
• Instituto Nacional de Cancerología - INC (Colombia): Colombia's public national cancer institute providing comprehensive oncology treatment as a government-designated reference center. Directly comparable to CON as a publicly operated specialty oncology hospital serving a defined geographic catchment in Latin America.
• INEN - Instituto Nacional de Enfermedades Neoplásicas (Peru): Peru's public national specialty cancer hospital offering comprehensive oncology services (radiotherapy, chemotherapy, surgery, palliative care). Operates as a government-mandated referral center for its country — directly analogous to CON's role as regional public oncology reference center.
• SOLCA (Sociedad de Lucha Contra el Cáncer - Ecuador): Ecuador's network of public/non-profit regional cancer hospitals, each serving a defined geographic catchment with comprehensive oncology services. Operates a hub-and-spoke model across Ecuador — directly comparable to CON's role within Chile's Macrozona Norte.

Broad incumbents

• MD Anderson Cancer Center: The world's leading specialty oncology hospital and broader incumbent reference benchmark. While not directly competing (US-based, global referral destination), MD Anderson sets the operating, accreditation, and clinical research standards to which facilities like CON (via IAEA audits) are benchmarked.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/centro-oncol%C3%B3gico-del-norte

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro Oncológico Del Norte